[English] 日本語
Yorodumi- PDB-9cwr: SARS-CoV-2 BA.2.86 Spike trimer in complex with TRI2-2 minibinder -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9cwr | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | SARS-CoV-2 BA.2.86 Spike trimer in complex with TRI2-2 minibinder | ||||||||||||||||||||||||
Components |
| ||||||||||||||||||||||||
Keywords | VIRAL PROTEIN / Sarbecoviruses / Spike glycoprotein / Structural Genomic / inhibitor / minibinder / Structural Genomics / Seattle Structural Genomics Center for Infectious Disease / SSGCID | ||||||||||||||||||||||||
| Biological species | ![]() synthetic construct (others) | ||||||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.4 Å | ||||||||||||||||||||||||
Authors | Lee, J. / Veesler, D. / Seattle Structural Genomics Center for Infectious Disease (SSGCID) | ||||||||||||||||||||||||
| Funding support | United States, 1items
| ||||||||||||||||||||||||
Citation | Journal: Commun Biol / Year: 2026Title: The computationally designed TRI2-2 miniprotein inhibitor protects against multiple SARS-CoV-2 Omicron variants. Authors: Jimin Lee / James Brett Case / Young-Jun Park / Rashmi Ravichandran / Daniel Asarnow / M Alejandra Tortorici / Jack T Brown / Shilpa Sanapala / Lauren Carter / David Baker / Michael S Diamond / David Veesler / ![]() Abstract: The continued evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has compromised neutralizing antibody responses elicited by prior infection or vaccination and abolished the ...The continued evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has compromised neutralizing antibody responses elicited by prior infection or vaccination and abolished the utility of most monoclonal antibody therapeutics. We previously described a computationally-designed, homotrimeric miniprotein inhibitor, designated TRI2-2, that protects mice against pre-Omicron SARS-CoV-2 variants. Here, we show that TRI2-2 exhibits broadly neutralizing activity of SARS-CoV-2 variants and protects mice against BQ.1.1, XBB.1.5 and BA.2.86 challenge when administered intranasally post-exposure. The resistance of TRI2-2 to viral escape by most variants and the ability to deliver it directly to the upper airways highlight the potential of the multivalent miniprotein inhibitor as an alternative therapeutic modality. | ||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9cwr.cif.gz | 628.4 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9cwr.ent.gz | 473.6 KB | Display | PDB format |
| PDBx/mmJSON format | 9cwr.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9cwr_validation.pdf.gz | 2.4 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9cwr_full_validation.pdf.gz | 2.4 MB | Display | |
| Data in XML | 9cwr_validation.xml.gz | 85.8 KB | Display | |
| Data in CIF | 9cwr_validation.cif.gz | 140.7 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/cw/9cwr ftp://data.pdbj.org/pub/pdb/validation_reports/cw/9cwr | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 45972MC ![]() 9cwpC ![]() 9cwqC C: citing same article ( M: map data used to model this data |
|---|
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 141503.062 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Production host: Homo sapiens (human)#2: Protein | Mass: 17565.787 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) synthetic construct (others) / Production host: ![]() #3: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source #4: Sugar | ChemComp-NAG / #5: Water | ChemComp-HOH / | Has ligand of interest | N | Has protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: SARS-CoV-2 BA.2.86 Spike trimer in complex with TRI2-2 minibinder Type: COMPLEX / Entity ID: #1-#2 / Source: RECOMBINANT |
|---|---|
| Source (natural) | Organism: Sarbecovirus sp. |
| Source (recombinant) | Organism: Homo sapiens (human) |
| Buffer solution | pH: 8 |
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 1800 nm / Nominal defocus min: 800 nm |
| Image recording | Electron dose: 53.25 e/Å2 / Film or detector model: GATAN K3 (6k x 4k) |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.4 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 811069 / Symmetry type: POINT | ||||||||||||||||||||||||
| Refinement | Highest resolution: 2.4 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi





United States, 1items
Citation




PDBj
Homo sapiens (human)



FIELD EMISSION GUN